Living Well with Multiple Sclerosis
Health & Fitness:Fitness
Welcome to Living Well with MS, where we are pleased to welcome Dr Stefano Pluchino as our guest! Dr Pluchino is a Professor of Regenerative Neuroimmunology at Cambridge University and has been researching stem cell therapy for progressive MS. In this episode, Dr Pluchino speaks to Geoff about what advanced cell therapy is, the success of his phase one trial and what the future of DMTs looks like indicating what people with MS may experience.
Watch this episode on YouTube here. Keep reading for the key episode takeaways.
Topics and Timestamps:01:31 Dr Pluchino’s background and research into stem cell therapy for progressive MS.
02:52 The difference between types of MS.
05:09 Navigating DMT options for progressive MS.
08:40 Dr Pluchino’s advanced cell therapy research trial: The success of phase one and plans for phase two.
21:05 How advanced cell therapy compares to HSCT or bone marrow transplants.
26:02 What it means for the future of DMTs.
33:39 How you can be part of groundbreaking MS research and trials.
Selected Key Takeaways:There are nuances in types of MS beyond ‘relapsing’ or ‘progressive’.
04:23 "It is becoming more complex between active and non-active types of primary and secondary progressive MS where activity is attributed to other episodes. Clinical episodes of disease or radiologically evident episodes of disease, which can be identified by the use of contrast agents at the time of the MRI. So, they are very complex very heterogenous types of disease, with or without activity, which inevitably undergo accumulation of neurological deficits.”
The next generation of DMTs will target progression rather than relapses.
06:39 “What's becoming very interesting is that [over the last] few years, there is a general worldwide consensus that progressive MS is becoming and has become a clinical unmet need. The old MS world is concentrating on financing, funding and efforts towards stopping MS through the development of a new generation of DMDs which will eventually target progression rather than relapses.”
The future of advanced cell therapy research will look at remyelination, reduction of inflammation and neuroprotection.
19:10 "There is space for assessing whether a proportion of the injected cells [can] differentiate in vivo into new myelin-forming cells. There is a space to assess whether some of the cells [can] increase the survival of neurons in the brain. There is space to assess whether the transplanted cells [can] reduce the type of inflammation which characterises progressive MS, which is what we call a smouldering inflammation.
These highly diffuse homogeneous, low-level activations of microglia (immune cells of the central nervous system) and astrocytes (star-shaped cells that hold nerve cells in place) might be reduced by means of advanced cell therapy and the reason why I am specifically alluding to these three major biological mechanisms of disease, remyelination, reduction of inflammation and neuroprotection is because we have managed to identify each of these mechanisms in clinically relevant animal disease models in the last 25 years. So, there is [an] expectation that a clinical trial designed in a way that will allow us to establish the efficacy of the treatment will reveal what we have established already in one of these models.”
Want to learn more about living a full and happy life with multiple sclerosis? Sign up to our newsletter to hear our latest tips.
More info and links:Subscribe to this podcast and never miss an episode. Listen to our archive of Living Well with MS episodes here. If you like Living Well with MS, please leave a 5-star review.
Feel free to share your comments and suggestions for future guests and episode topics by emailing podcast@overcomingms.org.
Make sure you sign up to our newsletter to hear our latest tips and news about living a full and happy life with MS.
Support us:If you enjoy this podcast and want to support the ongoing work of Overcoming MS, we would really appreciate it if you could leave a donation here. Every donation, however small, helps us to share the podcast with more people on how to live well with MS.
Coffee Break #10 with Roy Bartlett | S2E28 bonus
Oils and OMS: Separating Facts from Fiction | S2E28
Coffee Break #9 with Rowan Baker | S2E27 bonus
How to Juice Up Exercise for People with MS | S2E27
Coffee Break #8 with Geoff Allix | S2E26 bonus
Welcoming Grazina Berry, New CEO of OMS | S2E26
Coffee Break #7 with Trishna Bharadia | S2E25 bonus
OMS from a Neurologist's POV | S2E25
Coffee Break #6 with Johanna Lahr | S2E24 bonus
Top Hacks for Getting into a Meditation Habit | S2E24
Coffee Break #5 with Sean Kressinger | S2E23 bonus
Building Community Through OMS Circles | S2E23
Coffee Break #4 with Natalie Cooper | S2E22 bonus
In Conversation with Caroline Clarke | S2E22
Coffee Break #3 with Sarah T | | S2E21 bonus
Gut Health - Your Microbiome and You | S2E21
Coffee Break #2 with Vicky Argyle | | S2E20 bonus
Journaling as a Path to Healing | S2E20
Coffee Break #1 with Maisie Markham | | S2E19 bonus
The COVID-19 Crisis and MS | S2E19
Create your
podcast in
minutes
It is Free
Good Mood Revolution
The Relaxback UK Show
Your Sleep Guru Podcast
Anxiety Slayer™ with Shann and Ananga
Sweat Daily with Kayla Itsines
Well Beyond 40